Generic Drug Industry in Europe Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

You might be interested in: Generics, Biosimilars, Generic Drugs, more »

34 reports

Download Unlimited Documents from Trusted Public Sources

Generic Drug Market Revenue - Forecast

  • June 2013
    13 pages
  • Generic Drug  

  • India  

    Europe  

    Asia  

View report >

Biosimilars Market Forecast in Europe

  • September 2014
    2 pages
  • Biosimilars  

    Drug  

  • Europe  

    Spain  

    World  

View report >

The future of the Generic Drug Industry in Europe

  • January 2014
    2 pages
  • Asthma  

  • Europe  

    United States  

    United Kingdom  

View report >

Biosimilars Market Share in Europe - Forecast

  • January 2014
    2 pages
  • Biosimilars  

  • Spain  

    Europe  

    Germany  

View report >

Biosimilars Spending - Forecast

  • January 2014
  • Biosimilars  

    Therapeutics  

  • United States  

    Europe  

View report >

Global Generics Industry - Forecast

  • March 2013
    23 pages
  • Generics  

  • Spain  

    World  

    Europe  

View report >

The future of the Biosimilars Industry

  • January 2013
    17 pages
  • Biosimilars  

    Biosimilar  

  • Europe  

    United States  

    World  

View report >

Biosimilars Markets in Europe - Forecast

  • January 2013
    20 pages
  • Biosimilars  

  • Europe  

    United States  

View report >

Global Generics Markets - Forecast

  • January 2013
    4 pages
  • Generics  

  • Europe  

    World  

    Canada  

View report >

Generics Market

  • July 2012
    6 pages
  • Generics  

  • India  

    United States  

    Europe  

View report >

Search in Generic Drug Industry

45 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 300 - $ 600)

Fesoterodine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Fesoterodine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

Frovatriptan - Patent, Extension And Data Exclusivity ...

October 2014 $ 653

Galantamine - Patent, Extension And Data Exclusivity E ...

October 2014 $ 653

Ibandronic Acid - Patent, Extension And Data Exclusivi ...

October 2014 $ 653

Imatinib - Patent, Extension And Data Exclusivity Expi ...

October 2014 $ 653

Lasofoxifene - Patent, Extension And Data Exclusivity ...

October 2014 $ 653

Pitavastatin - Patent, Extension And Data Exclusivity ...

October 2014 $ 653

Prasugrel - Patent, Extension And Data Exclusivity Exp ...

October 2014 $ 653

Rizatriptan - Patent, Extension And Data Exclusivity E ...

October 2014 $ 653

Valganciclovir - Patent, Extension And Data Exclusivit ...

October 2014 $ 653


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.